NanoViricides Inc. (NNVC)

[drkazmd65]

WBH - welcome.

A bit of reading on the sets of recent PRs, and a review of the posts on this board should be enough to get you started out nicely.

The posters here are generally well informed, and there is a diversity of opinion regarding some of the remaining 'up in the air' pieces of what the company is working on.

There is always danger of dilution in developmental stage companies - that being said, reportedly we have enough cash in hand already present that nothing overly creative will need to be done in order to get the current projects through the next year or two.

One drug candidate (Flucide) is gearing up for TOX studies and Phase I/II testing and 'should' be on track to get that work started by sometime in 2014. Currently a production facility is being renovated, and it is expected to be ready for test batch production before calendar year 2014. We'll see if that stays on schedule.

Company also has just recieved 'orphan drug' status on another formulation of it's tech aimed at the virus that causes Dengue Feaver. Work on evaluation of that drug candidate will likely follow in short order once the Flucide work is rolling.

Still lots of 'IFs' and potential stumbling blocks - but overall it looks good for a company with no actual product (yet) and no real revenue stream (yet).